Literature DB >> 27295274

Down-Regulation of Neuregulin1/ErbB4 Signaling in the Hippocampus Is Critical for Learning and Memory.

Jia Tian1,2, Fei Geng1, Feng Gao1, Yi-Hua Chen1, Ji-Hong Liu1, Jian-Lin Wu1, Yu-Jie Lan1, Yuan-Ning Zeng1, Xiao-Wen Li1, Jian-Ming Yang1, Tian-Ming Gao3.   

Abstract

Hippocampal function is important for learning and memory, and dysfunction of the hippocampus has been linked to the pathophysiology of neuropsychiatric diseases such as schizophrenia. Neuregulin1 (NRG1) and ErbB4, two susceptibility genes for schizophrenia, reportedly modulate long-term potentiation (LTP) at hippocampal Schaffer collateral (SC)-CA1 synapses. However, little is known regarding the contribution of hippocampal NRG1/ErbB4 signaling to learning and memory function. Here, quantitative real-time PCR and Western blotting were used to assess the mRNA and protein levels of NRG1 and ErbB4. Pharmacological and genetic approaches were used to manipulate NRG1/ErbB4 signaling, following which learning and memory behaviors were evaluated using the Morris water maze, Y-maze test, and the novel object recognition test. Spatial learning was found to reduce hippocampal NRG1 and ErbB4 expression. The blockade of NRG1/ErbB4 signaling in hippocampal CA1, either by neutralizing endogenous NRG1 or inhibiting/ablating ErbB4 receptor activity, enhanced hippocampus-dependent spatial learning, spatial working memory, and novel object recognition memory. Accordingly, administration of exogenous NRG1 impaired those functions. More importantly, the specific ablation of ErbB4 in parvalbumin interneurons also improved learning and memory performance. The manipulation of NRG1/ErbB4 signaling in the present study revealed that NRG1/ErbB4 activity in the hippocampus is critical for learning and memory. These findings might provide novel insights on the pathophysiological mechanisms of schizophrenia and a new target for the treatment of Alzheimer's disease, which is characterized by a progressive decline in cognitive function.

Entities:  

Keywords:  ErbB4; Hippocampus; Learning; Memory; NRG1; Parvalbumin interneurons

Mesh:

Substances:

Year:  2016        PMID: 27295274     DOI: 10.1007/s12035-016-9956-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  66 in total

1.  Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences.

Authors:  Hau-Jie Yau; Hsiao-Fang Wang; Cary Lai; Fu-Chin Liu
Journal:  Cereb Cortex       Date:  2003-03       Impact factor: 5.357

2.  Loss of recent memory after bilateral hippocampal lesions.

Authors:  W B SCOVILLE; B MILNER
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-02       Impact factor: 10.154

3.  T-maze alternation in the rodent.

Authors:  Robert M J Deacon; J Nicholas P Rawlins
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  Hippocampal pathology in schizophrenia.

Authors:  Stephan Heckers; Christine Konradi
Journal:  Curr Top Behav Neurosci       Date:  2010

Review 5.  Towards a functional organization of episodic memory in the medial temporal lobe.

Authors:  Howard Eichenbaum; Magdalena Sauvage; Norbert Fortin; Robert Komorowski; Paul Lipton
Journal:  Neurosci Biobehav Rev       Date:  2011-07-23       Impact factor: 8.989

6.  Specific regulation of NRG1 isoform expression by neuronal activity.

Authors:  Xihui Liu; Ryan Bates; Dong-Min Yin; Chengyong Shen; Fay Wang; Nan Su; Sergei A Kirov; Yuling Luo; Jian-Zhi Wang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

7.  The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders.

Authors:  Alon Shamir; Oh-Bin Kwon; Irina Karavanova; Detlef Vullhorst; Elias Leiva-Salcedo; Megan J Janssen; Andres Buonanno
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

Review 8.  Clearance systems in the brain-implications for Alzheimer disease.

Authors:  Jenna M Tarasoff-Conway; Roxana O Carare; Ricardo S Osorio; Lidia Glodzik; Tracy Butler; Els Fieremans; Leon Axel; Henry Rusinek; Charles Nicholson; Berislav V Zlokovic; Blas Frangione; Kaj Blennow; Joël Ménard; Henrik Zetterberg; Thomas Wisniewski; Mony J de Leon
Journal:  Nat Rev Neurol       Date:  2015-07-21       Impact factor: 42.937

9.  HDAC inhibition facilitates the switch between memory systems in young but not aged mice.

Authors:  Malorie Dagnas; Jean-Louis Guillou; Thomas Prévôt; Nicole Mons
Journal:  J Neurosci       Date:  2013-01-30       Impact factor: 6.167

10.  Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse.

Authors:  Mari S Golub; Stacey L Germann; K C Kent Lloyd
Journal:  Behav Brain Res       Date:  2004-08-12       Impact factor: 3.332

View more
  11 in total

1.  Neuroinflammation-Induced Downregulation of Hippocampacal Neuregulin 1-ErbB4 Signaling in the Parvalbumin Interneurons Might Contribute to Cognitive Impairment in a Mouse Model of Sepsis-Associated Encephalopathy.

Authors:  Rong Gao; Mu-Huo Ji; Da-Peng Gao; Run-Hua Yang; Shao-Gang Zhang; Jian-Jun Yang; Jin-Chun Shen
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

2.  Prenatal dexamethasone exposure induces anxiety- and depressive-like behavior of male offspring rats through intrauterine programming of the activation of NRG1-ErbB4 signaling in hippocampal PV interneurons.

Authors:  Shuai Zhang; Shuwei Hu; Wanting Dong; Songqiang Huang; Zhexiao Jiao; Zewen Hu; Shiyun Dai; Yiwen Yi; Xiaohan Gong; Ke Li; Hui Wang; Dan Xu
Journal:  Cell Biol Toxicol       Date:  2021-06-29       Impact factor: 6.691

3.  The Expression of Hippocampal NRG1/ErbB4 Correlates With Neuronal Apoptosis, but Not With Glial Activation During Chronic Cerebral Hypoperfusion.

Authors:  Yue Hei; Rong Chen; Xicai Yi; Lizhou Wei; Qianfa Long; Weiping Liu
Journal:  Front Aging Neurosci       Date:  2018-05-23       Impact factor: 5.750

4.  Increased Levels of Serum Neuregulin 1 Associated with Cognitive Impairment in Vascular Dementia.

Authors:  Xiaoling Wang; Fengyu Zhang; Weibin Ma; Depeng Feng; Jingjing Zhang; Jialei Xu
Journal:  Biomed Res Int       Date:  2020-11-12       Impact factor: 3.411

5.  Inhibitory Neural Network's Impairments at Hippocampal CA1 LTP in an Aged Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Hyeon Jeong Seo; Jung Eun Park; Seong-Min Choi; Taekyoung Kim; Soo Hyun Cho; Kyung-Hwa Lee; Woo Keun Song; Juhyun Song; Han-Seong Jeong; Dong Hyun Kim; Byeong C Kim
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

6.  MicroRNA-138 controls hippocampal interneuron function and short-term memory in mice.

Authors:  Reetu Daswani; Carlotta Gilardi; Michael Soutschek; Prakruti Nanda; Kerstin Weiss; Silvia Bicker; Roberto Fiore; Christoph Dieterich; Pierre-Luc Germain; Jochen Winterer; Gerhard Schratt
Journal:  Elife       Date:  2022-03-15       Impact factor: 8.713

7.  Claudin-5 relieves cognitive decline in Alzheimer's disease mice through suppression of inhibitory GABAergic neurotransmission.

Authors:  Ning Zhu; Meidan Wei; Linguang Yuan; Xiaodan He; Chunli Chen; Aimin Ji; Guozeng Zhang
Journal:  Aging (Albany NY)       Date:  2022-04-26       Impact factor: 5.682

8.  Extreme Glycemic Fluctuations Debilitate NRG1, ErbB Receptors and Olig1 Function: Association with Regeneration, Cognition and Mood Alterations During Diabetes.

Authors:  Madhavi Joshi; Dhriti P Shah; Amee Krishnakumar
Journal:  Mol Neurobiol       Date:  2021-06-24       Impact factor: 5.590

9.  CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer's disease.

Authors:  François Mouton-Liger; Julien Dumurgier; Emmanuel Cognat; Claire Hourregue; Henrik Zetterberg; Hugo Vanderstichele; Eugeen Vanmechelen; Elodie Bouaziz-Amar; Kaj Blennow; Jacques Hugon; Claire Paquet
Journal:  Alzheimers Res Ther       Date:  2020-07-20       Impact factor: 6.982

Review 10.  In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia.

Authors:  Oliwia Koszła; Katarzyna M Targowska-Duda; Ewa Kędzierska; Agnieszka A Kaczor
Journal:  Biomolecules       Date:  2020-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.